A new, patented technology, SmartVac allows 100% safe, consistent and accurate in-ovo vaccination and nutrition. It delivers the injectables only into the amniotic fluid, thus preventing possible injury to the growing embryo.
SmartVac will enable the poultry industry to apply a wide range of vaccines in-ovo, including Gumboro, Marek, ND and Coccidiosis vaccines. This is optionally performed in combination with nutritional components – for chickens with a healthy gut, favourable microbiota, enhanced immunity, and thus improved field performance.
SmartVac is designed to maximise the safety of the injection process, by focusing on the development level and needs of the growing embryo. The Embryo Soft Touch® EST® sensor on the injector allows automatic and individual adaptation of the injection depth to each single embryo, regardless of egg and embryo size. EST® also detects when the setter tray has an empty egg position, or contains non-viable eggs (infertiles or early deads), helping to reduce wastage of valuable vaccine. Only eggs containing grown embryos are inoculated with vaccine or nutrition.
Bouke Hamminga, Royal Pas Reform’s director of sales & business development, will deliver a session on SmartVac, the next-generation in-ovo vaccination and nutrition, in the 2022 IPPE TECHTalks programme.
SmartVac: the next generation of in-ovo vaccination and nutrition
18 January 2022
Royal Pas Reform has announced the launch of its latest innovation in early nutrition and animal welfare-friendly production practices. The SmartVac in-ovo vaccination and nutrition system will be officially unveiled to a global audience at IPPE 2022 in Atlanta.